Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agents
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Hamideh Ahadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Quinolones, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Mazandaran University of Medical Sciences.
Abstract (Originalsprache)
Levofloxacin, the optical S ‐(‐) isomer of ofloxacin, is a broad‐spectrum antibacterial agent widely used to control various infections caused by Gram‐positive and Gram‐negative bacteria. While the COOH group is necessary for antibacterial activity, its modification can offer anticancer activity to the fluoroquinolone framework. Therefore, several levofloxacin carboxamides 11a‐j and 12 containing 5‐substituted‐1,3,4‐thiadiazole residue were synthesized and screened in vitro for their anticancer activity. The in vitro MTT viability assay revealed that the most compounds had significant activity against cancer cells MCF‐7, A549, and SKOV3. In particular, the 3‐chloro‐ and 4‐fluoro‐ benzyl derivatives ( 11b and 11h ), with IC 50 values of 1.69–4.76 μM were as potent as or better than doxorubicin. It should be noted that the mother quinolone levofloxacin showed no activity on the tested cancer cell lines. The SAR analysis demonstrated that the 3‐chloro or 4‐fluoro substituent on the S ‐benzyl moiety had positive effect on the activity. Further in vitro evaluations of the most promising compounds 11b and 11h by flow cytometric analysis and comet test revealed the ability of compounds in the induction of apoptosis and blockage of the cell proliferation at the G1‐phase by nuclear fragmentation and DNA degradation in cancer cells. The obtained results demonstrated that the alteration of 6‐COOH functional group in the levofloxacin structure and conjugation with a proper heterocyclic pharmacophore is a good strategy to obtain new anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
- Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Förderung
- Mazandaran University of Medical Sciences
Zitieren
APA
Ahadi, H., Shokrzadeh, M., Hosseini-Khah, Z., Ghassemi Barghi, N., Ghasemian, M., & Emami, S. (2023). Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agents. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23334
Vancouver
Ahadi H, Shokrzadeh M, Hosseini-Khah Z, Ghassemi Barghi N, Ghasemian M, Emami S. Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agents. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23334
BibTeX
@article{Ahadi2023,
author = {Ahadi, Hamideh and Shokrzadeh, Mohammad and Hosseini-Khah, Zahra and Ghassemi Barghi, Nasrin and Ghasemian, Majid and Emami, Saeed},
title = {Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agents},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23334}
}
EUVIMED